Vistin Pharma ASA Provides Production and Earnings Guidance for the Second Quarter of 2022
The financial results are expected to improve from the second quarter of 2022 with more volumes available for sale.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.4 NOK | 0.00% | +1.82% | -3.86% |
05-23 | Vistin Pharma ASA Approves Ordinary Dividend | CI |
04-24 | Vistin Pharma ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-3.86% | 93.97M | |
+18.04% | 42.95B | |
+16.92% | 21.38B | |
+18.33% | 15.05B | |
+19.27% | 14.45B | |
+56.12% | 13.04B | |
-0.05% | 6.79B | |
-10.73% | 6.72B | |
-8.87% | 5.73B | |
+11.21% | 5.47B |